Prof. Peter Weber untersucht mit EU-Kollegen die Wechselwirkungen von Medikamenten und Nahrung [21.08.17]
Ernährung, medikamentöse Behandlung und Gesundheit sind eng miteinander verbunden. Daher sind Bewusstsein, Aufmerksamkeit und individuelle Strategien erforderlich, um mögliche negative Auswirkungen durch die Wechselwirkung zwischen Arznei- und Nahrungsmitteln zu erkennen und im Sinne der Gesundheit zu beeinflussen.
Eur J Nutr. 2017 Jul 26. doi: 10.1007/s00394-017-1510-3. [Epub ahead of print]: Public health relevance of drug-nutrition interactions | Péter S, Navis G, de Borst MH, von Schacky C, van Orten-Luiten ACB, Zhernakova A, Witkamp RF, Janse A, Weber P, Bakker SJL, Eggersdorfer M. | PMID: 28748481, DOI:10.1007/s00394-017-1510-3
Zusammenfassung (Abstract in English):
The public health relevance of drug-nutrition interactions is currently highly undervalued and overlooked. This is particularly the case for elderly persons where multi-morbidity and consequently polypharmacy is very common. Vitamins and other micronutrients have central functions in metabolism, and their interactions with drugs may result in clinically relevant physiological impairments but possibly also in positive effects. On 12 April 2016, the University Medical Center Groningen (The Netherlands), as part of its Healthy Ageing program, organized a workshop on the public health relevance of drug-nutrient interactions. In this meeting, experts in the field presented results from recent studies on interactions between pharmaceuticals and nutrients, and discussed the role of nutrition for elderly, focusing on those persons receiving pharmaceutical treatment. This paper summarizes the proceedings of the symposium and provides an outlook for future research needs and public health measures. Since food, pharma and health are closely interconnected domains, awareness is needed in the medical community about the potential relevance of drug-nutrition interactions. Experts and stakeholders should advocate for the integration of drug-nutrition evaluations in the drug development process. Strategies for the individual patients should be developed, by installing drug review protocols, screening for malnutrition and integrating this topic into the general medical advice.